Sells the DeltaWave nasal-pillows CPAP interface for sleep apnea treatment to durable medical equipment providers, hospitals and sleep-care professionals.
10-K for FY2025, filed Apr 15, 2026Our former CEO invented our DeltaWave CPAP interface (the “DeltaWave”) as an innovative new device to treat patients with sleep apnea. Our…View ↗
Our target market includes:View ↗
During the year ended December 31, 2025, we recognized revenue and cost of goods for the sale of the DeltaWave of $16,721 and $12,707…View ↗
$16.7K
10-K for FY2025, filed Apr 15, 2026
$16.7K ↗
Targets durable medical equipment providers, hospitals and acute-care facilities, and sleep-care professionals; it plans to reach buyers through hospital distributors and online retailers.
10-K for FY2025, filed Apr 15, 2026Market to Durable Medical Equipment providersView ↗
Secure agreement(s) with hospital distributors for acute care salesView ↗
Secure agreements with Internet retailers for online salesView ↗
Our target market includes:View ↗
We expect that most of our revenue will be through durable medical equipment providers and hospital target market.View ↗
The nationwide sales team is meeting with customers to introduce the product. The average sales cycle for a Durable Medical Equipment…View ↗
No. It lost $3M in FY2025.
10-K for FY2025, filed Apr 15, 2026
8-K, filed Aug 28, 2026
On July 17, 2026, Fruci & Associates II, PLLC (“Fruci”), the independent registered public accounting firm of REMSleep Holdings, Inc. (the…View ↗
8-K, filed Jun 4, 2026
Through these off-the-market transactions, 1000152403 ONTARIO INC (an Ontario Canada Corp) . acquired control of RemSleep Holdings Inc…View ↗
Shrinking. Revenue fell 95% in 3 years, from $320.7K in FY2022 to $16.7K in FY2025, about 63% a year.
From development to sales
The older report described DeltaWave as patent-pending and still under development; the latest report describes patented DeltaWave products being sold and says CPAP machine sales stopped.
10-K for FY2022, filed Apr 17, 2023 10-K for FY2025, filed Apr 15, 2026Our officers have 35 years of sleep-industry experience, including having been employed at sleep industry companies. Our officers invented…View ↗
Pending adequate financing, we plan to conduct clinical trials to test product effectiveness.View ↗
On June 28, 2016, we applied for a patent for a new, innovative sleep apnea product that serves as an interface for the delivery of CPAP…View ↗
Competes with ResMed
10-K for FY2025, filed Apr 15, 2026ResMedView ↗
Loading...